Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

Summary

The primary objective of the study is to determine the safety of single doses of orally administered EDP-788. Secondary objectives of the study are: * To describe the pharmacokinetics of EDP-788 (and its metabolite EDP-322) after single doses of orally administered drug * To estimate the bioavailability of EDP-788 capsules relative to an oral liquid suspension * To estimate the effect of co-administration of food on the absorption of EDP-788

Timeline

Start

2014-01

Primary completion

2014-09

Completion

2014-09

Drugs

Indications

No indication recorded.